Source: Neuromuscular Disorders. Unidade: IB
Assunto: GENÉTICA MÉDICA
ABNT
ROSENBERG, Carla et al. Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization. Neuromuscular Disorders, v. 8, p. 417-452, 1998Tradução . . Disponível em: https://doi.org/10.1016/s0960-8966(98)00050-9. Acesso em: 28 out. 2024.APA
Rosenberg, C., Navajas, L., Vagenas, D. F., Bakker, E., Vainzof, M., Passos-Bueno, M. R., et al. (1998). Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization. Neuromuscular Disorders, 8, 417-452. doi:10.1016/s0960-8966(98)00050-9NLM
Rosenberg C, Navajas L, Vagenas DF, Bakker E, Vainzof M, Passos-Bueno MR, Takata RI, Van Ommen GJB, Zatz M, Den Dunnen JT. Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization [Internet]. Neuromuscular Disorders. 1998 ; 8 417-452.[citado 2024 out. 28 ] Available from: https://doi.org/10.1016/s0960-8966(98)00050-9Vancouver
Rosenberg C, Navajas L, Vagenas DF, Bakker E, Vainzof M, Passos-Bueno MR, Takata RI, Van Ommen GJB, Zatz M, Den Dunnen JT. Clinical diagnosis of heterozygous dystrophin gene deletions by fluorescence in situ hybridization [Internet]. Neuromuscular Disorders. 1998 ; 8 417-452.[citado 2024 out. 28 ] Available from: https://doi.org/10.1016/s0960-8966(98)00050-9